The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKore Potash Regulatory News (KP2)

Share Price Information for Kore Potash (KP2)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.525
Bid: 0.50
Ask: 0.55
Change: 0.00 (0.00%)
Spread: 0.05 (10.00%)
Open: 0.525
High: 0.525
Low: 0.525
Prev. Close: 0.525
KP2 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CDI Monthly Movement

7 Dec 2023 07:00

RNS Number : 9242V
Kore Potash PLC
07 December 2023
 

 

 

7 December 2023

Kore Potash Plc

("Kore Potash" or the "Company")

CDI Monthly Movement

 

Kore Potash (ASX: KP2, AIM: KP2, JSE: KP2) advises the following movements in CDIs over its ordinary shares during November 2023:

 

Balance - 31 October 2023

669,057,520

Net Movement*

948,524

Balance - 30 November 2023

670,006,044

 

* Increase/(Decrease) in the number of CDIs quoted on ASX as a result of transfers between CDIs quoted on ASX and ordinary shares quoted on AIM and JSE, as required by the ASX to be reported on a minimum monthly basis.

 

A copy of the Appendix 4A lodged with the ASX is attached below.

 

 

ENDS

 

For further information, please visit www.korepotash.com or contact:

 

Kore Potash

David Hathorn - Chairman

 

Tel: +27 84 603 6238

Tavistock Communications

Nick Elwes

Adam Baynes

 

Tel: +44 (0) 20 7920 3150

SP Angel Corporate Finance - Nomad and Joint Broker

Ewan Leggat

Charlie Bouverat

 

Tel: +44 (0) 20 7470 0470

Shore Capital - Joint Broker

Toby Gibbs

James Thomas

 

Tel: +44 (0) 20 7408 4050

Questco Corporate Advisory - JSE Sponsor

Doné Hattingh  

 

Tel: +27 (11) 011 9205

 

 

Appendix 4A

Statement of CDIs on issue

Information and documents given to ASX become ASX's property and may be made public.

*Denotes minimum information required for first lodgement of this form.

Part 1 - Entity and announcement details

Question no

Question

Answer

1.1

*Name of entity

We (the entity named above) provide the following information about our issued capital.[1]

KORE POTASH PLC

1.2

*Registration type and number

Please supply your ABN, ARSN, ARBN, ACN or another registration type and number (if you supply another registration type, please specify both the type of registration and the registration number).

ARBN 621843614

1.3

*ASX issuer code

KP2

1.4

\* The announcement is

Tick whichever is applicable.

ü New announcement

Update/amendment to previous announcement

Cancellation of previous announcement

1.4a

*Reason for update

Mandatory only if "Update" ticked in Q1.4 above. A reason must be provided for an update.

N/A

1.4b

*Date of previous announcement to this update

Mandatory only if "Update" ticked in Q1.4 above.

N/A

1.4c

*Reason for cancellation

Mandatory only if "Cancellation" ticked in Q1.4 above.

N/A

1.4d

*Date of previous announcement to this cancellation

Mandatory only if "Cancellation" ticked in Q1.4 above.

N/A

1.5

*Date of this announcement

Thursday, 7 December 2023

Part 2 - Details of CDIs and other securities on issue

Question No.

Question

Answer

2.1

*Statement for month and year

Appendix 4A should be provided within 5 business days of the calendar month end, regardless of whether there is a change or not.

Month: November

Year: 2023

2.2

*Number and class of all ASX-quoted CDIs on issue:

Repeat the following information for each class of CDIs quoted on ASX

ASX security code:

KP2

Security description:

CHESS DEPOSITARY INTERESTS 1:1

CDI ratio[2]:

1:1

Total number of CDIs quoted on ASX at end of statement month (A):

670,006,044

Total number of CDIs quoted on ASX at end of previous month (B):

669,057,520

Net difference[3] (A-B):

 

948,524

Reason for change:

Net transfers of 948,524 securities between CDIs and ordinary shares as quoted / held on AIM and JSE.

 

If the total number of CDIs quoted on ASX at the end of the statement month (A), is greater than the total number of CDIs for which the entity has previously paid an initial listing fee or an additional listing fee under Table 1A and 1C of Guidance Note 15A (C), the entity hereby applies for +quotation of the difference (A - C) and agrees to the matters set out in Appendix 2A of the ASX Listing Rules.

 

2.3

*Number and class of all issued securities not represented by CDIs quoted on ASX:

Repeat the following table for each class of issued securities not represented (in whole or in part) by CDIs quoted on ASX

ASX security code:

KP2AA

Security description:

ORDINARY FULLY PAID

Total number of securities at end of statement month (A):

3,243,986,076

Total number of securities at end of previous month (B):

2,908,359,600

Net difference (A-B):

 

335,626,476

Reason for change:

Net transfers of 948,524 securities between CDIs and ordinary shares as quoted / held on AIM and JSE and an issue of 336,575,000 fully paid ordinary shares listed on AIM on 7 November 2023.

 

 

ASX security code:

KP2AB

Security description:

OPTION EXPIRING 19-JUL-2024 EX GBP 0.022

Total number of securities at end of statement month (A):

26,900,000

Total number of securities at end of previous month (B):

26,900,000

Net difference (A-B):

 

0

Reason for change:

Not applicable.

 

ASX security code:

KP2AF

Security description:

OPTION EXPIRING 01-JAN-2024 EX 2.2

Total number of securities at end of statement month (A):

20,000,000

Total number of securities at end of previous month (B):

20,000,000

Net difference (A-B):

 

0

Reason for change:

Not applicable.

 

 

Introduced 01/12/19

 


[1] Listing rule 4.11 requires an entity that has a dual listing on ASX and an overseas exchange and has CDIs issued over quoted securities, to complete an Appendix 4A and give it to ASX within 5 business days of the end of each month. An entity that has a dual listing on ASX and an overseas exchange and that is proposing to issue new equity securities and to have quoted CDIs over some or all of them, should notify ASX of the proposed issue of the underlying securities using an Appendix 3B and apply for the CDIs to be quoted using an Appendix 2A.

 

[2] This is the ratio at which CDIs can be transmuted into the underlying security (e.g. 4:1 means 4 CDIs represent 1 underlying security whereas 1:4 means 1 CDI represents 4 underlying securities).

[3] The net difference should equal the number of underlying securities transmuted into CDIs during the month less the number of CDIs transmuted into underlying securities during the month

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCQQLFBXLLFFBX
Date   Source Headline
24th Mar 202211:00 amRNSPrice Monitoring Extension
24th Mar 20229:05 amRNSSecond Price Monitoring Extn
24th Mar 20229:00 amRNSPrice Monitoring Extension
4th Mar 20227:00 amRNSCDI Monthly Movement
3rd Feb 20227:00 amRNSCDI Monthly Movement
20th Jan 20227:00 amRNSReview of Operations - Quarter ended 31 Dec 2021
19th Jan 20227:00 amRNSWebinar and Q&A: Potash
10th Jan 20227:00 amRNSCDI Monthly Movement
31st Dec 20217:00 amRNSChange of Adviser
6th Dec 20219:00 amRNSCDI Monthly Movement
1st Dec 20217:45 amRNSChange in Non-Executive Director
10th Nov 20217:00 amRNSKola Optimisation Study Interim Report
3rd Nov 20217:00 amRNSCDI Monthly Movement
25th Oct 20217:01 amRNSAppendix 5B
25th Oct 20217:00 amRNSReview of Operations - Quarter ended 30 Sept 2021
15th Oct 20217:00 amRNSWebinar and Q&A: Republic of Congo
5th Oct 20217:00 amRNSCDI Monthly Movement
3rd Sep 20217:51 amRNSCDI Monthly Movement
2nd Sep 20212:06 pmRNSSecond Price Monitoring Extn
2nd Sep 20212:00 pmRNSPrice Monitoring Extension
2nd Sep 20211:12 pmRNSChange in Non-Executive Director
24th Aug 20217:35 amRNSFinancial Report for Half Year Ended 30 June 2021
23rd Aug 20217:00 amRNSCancellation of Unlisted Options
4th Aug 20218:00 amRNSCDI Monthly Movement
27th Jul 20217:00 amRNSReview of Operations for Q2 2021
16th Jul 20217:30 amRNSManagement Changes
8th Jul 20217:00 amRNSIssue of Equity
2nd Jul 20218:25 amRNSCDI Monthly Movement
24th Jun 20217:13 amRNSIssue of New Options and Appendix 3G
9th Jun 20219:57 amRNSResults of AGM
9th Jun 20218:45 amRNSAppointment of CFO
4th Jun 20218:00 amRNSCDI Monthly Movement
2nd Jun 20219:47 amRNSRemote access to AGM
1st Jun 20219:22 amRNSCorrection - Issue of Equity, Rights and Options
1st Jun 20217:00 amRNSIssue of Equity, Performance Rights and Options
28th May 20212:49 pmRNSDirector/PDMR Shareholding
27th May 20212:00 pmRNSPrice Monitoring Extension
27th May 20217:00 amRNSDX Project drilling results and progress update
17th May 20217:00 amRNSNotice of AGM
11th May 20217:00 amRNSDirector/PDMR Shareholding
11th May 20217:00 amRNSCleansing Notice
5th May 20212:11 pmRNSResults of General Meeting and Issue of Shares
5th May 20218:00 amRNSCDI Monthly Movement
28th Apr 202111:15 amRNSRemote access to General Meeting
23rd Apr 20217:00 amRNSReview of Operations for Q1 2021
19th Apr 20217:00 amRNSNotice of GM
14th Apr 20219:34 amRNSASX Cleansing Announcement
9th Apr 20217:00 amRNSIssue of Equity
8th Apr 20216:30 pmRNSResults of Proposed Fundraise
8th Apr 20217:08 amRNSProposed Fundraise to raise approximately US$11m

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.